Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06357299 · ClinicalTrials.gov registry record · NA
Assessing Better Bottles for Babies
A NA study of Pediatric Obesity and Weight Gain Trajectory, sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 76
- Enrollment target
- 1
- Study location
NCT06357299: Recruiting NA study of Pediatric Obesity and Weight Gain Trajectory, sponsored by Duke University.
NCT06357299 is a NA study of Pediatric Obesity and Weight Gain Trajectory that is actively recruiting participants, run by Duke University. The registered enrollment target is 76 participants, below the 228-participant average among 45 other Pediatric Obesity trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06357299, a NA study of Pediatric Obesity and Weight Gain Trajectory, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will use a 2 x 2 factorial design to test impact of two intervention strategies (bottle size and bottle opacity) on infant weight gain.
Primary Outcome
CWGz scores will be calculated for each participant as the residual of the actual weight-for-age z-score at 4 months minus its predicted z-score from linear regression of the 4 month z-score on birth weight z-score. Intent-to-treat analyses will include regression models, stratified by sex, with CWGz score as the outcome.
Conditions Studied
Interventions
- BEHAVIORAL Small Bottle Size
- BEHAVIORAL Standard Bottle Size
- BEHAVIORAL Clear Bottle
- BEHAVIORAL Opaque Bottle
Study Locations (1)
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2025-05-28 |
| Est. Completion | 2026-05-01 |
| Phase | NA |
What NCT06357299 shows while recruiting
NCT06357299 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 228-participant average among 45 other Pediatric Obesity trials with a reported enrollment target (67% lower).
The record links to 3 conditions, with Pediatric Obesity appearing as the primary indexed condition, and to 4 interventions - of which Small Bottle Size is the first listed.
NCT06357299 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06357299 about?
NCT06357299 is a clinical study titled "Assessing Better Bottles for Babies". This study will use a 2 x 2 factorial design to test impact of two intervention strategies (bottle size and bottle opacity) on infant weight gain.
What is the current status of trial NCT06357299?
This trial is currently recruiting. It is a NA study. The enrollment target is 76 participants. The study started on 2025-05-28. Estimated completion is 2026-05-01.
What conditions does trial NCT06357299 study?
This clinical trial studies the following conditions: Pediatric Obesity, Weight Gain Trajectory, Infant Obesity.
What interventions are being tested in trial NCT06357299?
The interventions under investigation include: Small Bottle Size (BEHAVIORAL), Standard Bottle Size (BEHAVIORAL), Clear Bottle (BEHAVIORAL), Opaque Bottle (BEHAVIORAL).
Who is sponsoring clinical trial NCT06357299?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06357299 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatric Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06357299's enrollment target sits among peer trials
76 28th of 45 higher than 17 of 45 other Pediatric Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pediatric Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mechanistic Study of Inspiratory Training in Childhood Asthma (MICA)
RECRUITING · NA
-
iAmHealthy Clinical Practice Guideline (CPG)
RECRUITING · NA
-
Monitoring Eating Across Locations (MEAL) - Timing, Intake, and Mealtime Evaluation (TIME)
RECRUITING · NA
-
Nutrition and Obesity in Under-Represented Populations: Food Insecurity Research to Advance Science and Improve Health
RECRUITING · NA
-
Growing Healthy Children and Families in Rural Arkansas
RECRUITING · NA
-
Time Limited Eating in Adolescents With Type 2 Diabetes (KT2D)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI